Teva

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Teva
TickerTEVA
CIK #0000818686
CUSIP881624209
SectorLife Sciences
IndustryPharmaceutical Preparations
Phone
Address5 Bazel St PO B 3190
Petach Tikva, 49131
Source [EDGAR]
Market Cap, 13F ($BB)
604836241202011201320152018
Business

We are a global pharmaceutical company, committed to helping patients around the world to access affordable medicines and benefit from innovations to improve their health. Our mission is to be a global leader in generics, specialty medicines and biopharmaceuticals, improving the lives of patients.

We operate worldwide, with headquarters in Israel and a significant presence in the United States, Europe and many other markets around the world. Our key strengths include our world-leading generic medicines expertise and portfolio, focused specialty medicines portfolio and global infrastructure and scale.

Teva was incorporated in Israel on February 13, 1944 and is the successor to a number of Israeli corporations, the oldest of which was established in 1901.

CIK Filing 2011 - 2021
[0000818686] 10-K
[0000818686] 10-Q
[0000818686] 3
[0000818686] 4
[0000818686] 6-K
[0000818686] 8-K
[0000818686] SC 13D
[0000818686] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Wellington Management Group LLP TEVA Pharmaceutical Industries Ltd [2020-01-28] 7.43
Europacific Growth Fund TEVA Pharmaceutical Industries Ltd [2019-02-14] 5.1
Capital Research Global Investors TEVA Pharmaceutical Industries Ltd [2018-02-09] 9.7
Franklin Resources Inc TEVA Pharmaceutical Industries Ltd [2018-02-05] 6.3
TEVA Pharmaceutical Industries Ltd Mesoblast Ltd [2017-10-31] 14.7
Allergan PLC TEVA Pharmaceutical Industries Ltd [2016-08-08] 0.9
TEVA Pharmaceutical Industries Ltd Xenon Pharmaceuticals Inc [2016-03-30] 7.7
TEVA Pharmaceutical Industries Ltd Alexza Pharmaceuticals Inc [2016-03-28] 0.99
FMR LLC TEVA Pharmaceutical Industries Ltd [2016-02-12] 0.0
TEVA Pharmaceutical Industries Ltd Wave Life Sciences Ltd [2015-12-10] 9.0
TEVA Pharmaceutical Industries Ltd Auspex Pharmaceuticals Inc [2015-04-08] 30.0
Capital Research Global Investors TEVA Pharmaceutical Industries Ltd [2014-02-13] 5.1
[2012-02-14] None
Form 3/4/5 Filer 2011-2021
Schultz KARE
Daniell Richard
Hussain Abbas
Lieberman Gerald M
Halfon Jean Michel
Elstein Amir
Barer SOL J
Crane Rosemary A
Peres Nechemia Jacob
Nisen Perry
Mignone Roberto
Satchi-Fainaro Ronit
Vergis Janet S
Griffin Deborah A
Stark David Matthew
O'Grady Brendan P
Nazzi Gianfranco
Fridriksdottir Hafrun
Dethlefs Sven
Sabag Mark
Kalif Eliyahu Sharon
Drape Eric
McClellan Michael James
Goldberg Murray A
de Notaristefani Carlo
Codner IRIS Beck
Suesskind Dan S
Greene-Sulzberger Gabrielle
MAOR Galia
Cephalon Inc
Ignyta Inc
MM Shares Owned of 1,089.5 MM Total
Firm Period DFND Voting Shares
Capital Research Global Investors [2020-09-30] DFND 130.0 130.1
Capital World Investors [2020-09-30] DFND 52.8 52.8
Berkshire Hathaway Inc [2020-09-30] DFND 42.8 42.8
BlackRock Inc. [2020-09-30] SOLE 35.8 38.2
Abrams Capital Management LP [2020-09-30] SOLE 24.0 24.0
Capital Research & Management Co - Division 3 [2020-09-30] DFND 23.4 23.4
Migdal Insurance & Financial Holdings Ltd. [2020-09-30] DFND 17.5 17.5
State Street Corp [2020-09-30] DFND 11.5 16.5
Susquehanna International Group LLP [2020-09-30] DFND 4.5 15.7
Clal Insurance Enterprises Holdings Ltd [2020-09-30] DFND 13.9 13.9
Menora Mivtachim Holdings Ltd [2020-09-30] DFND 13.3 13.3
Phoenix Holdings Ltd. [2020-09-30] SOLE 11.0 11.0
Citigroup Inc [2020-09-30] DFND 10.4 10.4
Camber Capital Management LP [2020-09-30] SOLE 9.0 9.0
Credit Suisse AG [2020-09-30] DFND 8.4 8.4
Miller Value Partners LLC [2020-09-30] SOLE 8.1 8.1
Harel Insurance Investments & Financial Services Ltd. [2020-09-30] DFND 8.1 8.1
Northern Trust Corp [2020-09-30] DFND 5.2 7.5
Citadel Advisors LLC [2020-09-30] DFND 6.2 6.2
Goldman Sachs Group Inc [2020-09-30] DFND 4.4 4.7
Psagot Investment House Ltd. [2020-09-30] DFND 4.3 4.5
Geode Capital Management LLC [2020-09-30] DFND 4.3 4.3
Swiss National Bank [2020-09-30] SOLE 4.3 4.3
JPMorgan Chase & Co [2020-09-30] DFND 4.2 4.3
Beck Mack & Oliver LLC [2020-09-30] SOLE 4.0 4.1
Parametric Portfolio Associates LLC [2020-09-30] SOLE 3.6 3.8
Sumitomo Mitsui Trust Holdings, Inc. [2020-09-30] DFND 3.7 3.7
Arrowstreet Capital Limited Partnership [2020-09-30] DFND 2.3 3.4
Connor Clark & Lunn Investment Management Ltd [2020-09-30] SOLE 1.5 3.4
Mivtachim The Workers Social Insurance Fund Ltd. (Under Spec [2020-09-30] DFND 3.3 3.3
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com